000 | 01301 a2200373 4500 | ||
---|---|---|---|
005 | 20250514055936.0 | ||
264 | 0 | _c20030416 | |
008 | 200304s 0 0 eng d | ||
022 | _a0269-2813 | ||
024 | 7 |
_a10.1046/j.1365-2036.2003.01445.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrunner, M | |
245 | 0 | 0 |
_aGastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. _h[electronic resource] |
260 |
_bAlimentary pharmacology & therapeutics _cFeb 2003 |
||
300 |
_a395-402 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 |
_aGastrointestinal Transit _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Absorption _xphysiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesalamine _xadministration & dosage |
650 | 0 | 4 | _aTablets |
700 | 1 | _aAssandri, R | |
700 | 1 | _aKletter, K | |
700 | 1 | _aTschurlovits, M | |
700 | 1 | _aCorrado, M E | |
700 | 1 | _aVilla, R | |
700 | 1 | _aEichler, H G | |
700 | 1 | _aMüller, M | |
773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 17 _gno. 3 _gp. 395-402 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.2003.01445.x _zAvailable from publisher's website |
999 |
_c12361383 _d12361383 |